MS MAGDA POPIELA, Consultant Ophthalmologist and Clinical Director of Ophthalmology at Cardiff and Vale University Health Board has become the first ophthalmic surgeon in Wales to use the EndoArt Artificial Endothelial Implant, an innovative new treatment offering hope to patients with complex corneal conditions.
The innovative procedure was performed on mum-of-two Bethan, who suffers with a complex range of conditions which stem from congenital cataracts.
Bethan featured in series one of the BBC’s Saving Lives in Cardiff in 2024 which followed her undergoing a cornea transplant to help preserve what little sight she had left. Bethan has had numerous corneal transplants over the years with limited success, which is why she qualified for this new procedure.
The EndoArt implant is a synthetic implant inserted into the eye’s posterior corneal surface through a minimally invasive procedure. The cutting-edge technology offers an alternative to donor corneal tissue, offering patients with challenging cases an improved chance of a positive outcome.
Magda explained: “EndoArt reduces dependence on corneal donor availability and does not carry risk of rejection. Its use offers new treatment opportunity for patients with chronic endothelial dysfunction and significant corneal swelling.
“Bethan’s case represents historic milestone as she became first patient in Wales to receive EndoArt. This treatment option offers her and other patients with complex corneal disease new hope.”
Magda and her team were happy to discover that following the surgery and Bethan’s recovery, the graft is working well.
Bethan said: “I’m eternally grateful to Magda and the whole team for fighting for me and finding everything they can do to retain as much vision as possible.
“This procedure will make such a difference to people’s lives. I feel so privileged to be the first person in Wales to receive this groundbreaking surgery, it means so much to me.”
Rhys Andrews,General Manager of Ophthalmology at Cardiff and Vale University Health Board also commented: “Ms Popiela’s openness to innovation and dedication to exploring new technologies continues to place Cardiff and Vale at the forefront of ophthalmic care in Wales.
“Her commitment to advancing patient outcomes through evidence-based adoption of cutting-edge techniques exemplifies the very best of our clinical community.”
This milestone procedure not only supports Bethan’s personal journey but also promises hope for future patients facing the most complex corneal conditions.
